Abstract:Motivation: While drug combination therapies are a well-established concept in cancer treatment, identifying novel synergistic combinations is challenging due to the size of combinatorial space. However, computational approaches have emerged as a time- and cost-efficient way to prioritize combinations to test, based on recently available large-scale combination screening data. Recently, Deep Learning has had an impact in many research areas by achieving new state-of-the-art model performance. However, Deep Learning has not yet been applied to drug synergy prediction, which is the approach we present here, termed DeepSynergy. DeepSynergy uses chemical and genomic information as input information, a normalization strategy to account for input data heterogeneity, and conical layers to model drug synergies.Results: DeepSynergy was compared to other machine learning methods such as Gradient Boosting Machines, Random Forests, Support Vector Machines and Elastic Nets on the largest publicly available synergy dataset with respect to mean squared error. DeepSynergy significantly outperformed the other methods with an improvement of 7.2% over the second best method at the prediction of novel drug combinations within the space of explored drugs and cell lines. At this task, the mean Pearson correlation coefficient between the measured and the predicted values of DeepSynergy was 0.73. Applying DeepSynergy for classification of these novel drug combinations resulted in a high predictive performance of an AUC of 0.90. Furthermore, we found that all compared methods exhibit low predictive performance when extrapolating to unexplored drugs or cell lines, which we suggest is due to limitations in the size and diversity of the dataset. We envision that DeepSynergy could be a valuable tool for selecting novel synergistic drug combinations.Availability and implementation: DeepSynergy is available via www.bioinf.jku.at/software/DeepSynergy.Contact: klambauer@bioinf.jku.at.Supplementary information: Supplementary data are available at Bioinformatics online.

VQSynery: Robust Drug Synergy Prediction With Vector Quantization Mechanism

SynergyX: a multi-modality mutual attention network for interpretable drug synergy prediction

CCSynergy: an integrative deep-learning framework enabling context-aware prediction of anti-cancer drug synergy

Predicting drug synergy using a network propagation inspired machine learning framework

Anti-cancer Drug Synergy Prediction in Understudied Tissues using Transfer Learning

GraphSynergy: a network-inspired deep learning model for anticancer drug combination prediction

Trustworthy Deep Neural Network for Inferring Anticancer Synergistic Combinations

DKPE-GraphSYN: a drug synergy prediction model based on joint dual kernel density estimation and positional encoding for graph representation

DTSyn: a Dual-Transformer-based Neural Network to Predict Synergistic Drug Combinations

MMSyn: A New Multimodal Deep Learning Framework for Enhanced Prediction of Synergistic Drug Combinations

Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction

Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer

Few-Shot Drug Synergy Prediction With a Prior-Guided Hypernetwork Architecture

SynerGNet: A Graph Neural Network Model to Predict Anticancer Drug Synergy

A granularity-level information fusion strategy on hypergraph transformer for predicting synergistic effects of anticancer drugs

MFSynDCP: multi-source feature collaborative interactive learning for drug combination synergy prediction

CFSSynergy: Combining Feature-Based and Similarity-Based Methods for Drug Synergy Prediction

DeepSynergy: predicting anti-cancer drug synergy with Deep Learning

Prediction of Synergistic Anti-Cancer Drug Combinations Based on Drug Target Network and Drug Induced Gene Expression Profiles

Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning

ALNSynergy: a graph convolutional network with multi-representation alignment for drug synergy prediction